Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bernstein SocGen reduced its price target on Palo Alto Networks to $209 from $210 while retaining an Outperform rating after the cybersecurity provider reported second-quarter fiscal 2026 results that showed roughly 15% organic growth, a modest revenue beat, and next-generation security ARR that missed the top end of its guided organic range for th…
Stephens raised its price target on EQT to $71 from $70 and kept an Overweight rating after the natgas producer reported fourth-quarter 2025 results that outperformed consensus. EQT beat estimates across production, cash flow per share and free cash flow, drove lower well costs, and generated robust free cash flow for the year. Guidance for 2026 sh…
Bernstein SocGen Group reduced its price objective on Coca-Cola Europacific Partners (CCEP) to EUR72.50 from EUR73.10 while retaining a Market Perform rating. The company reported a solid finish to fiscal 2025 with 2.8% adjusted comparable, foreign-exchange-neutral revenue growth, operating profit growth of 7.1% and earnings per share slightly ahea…
Stephens raised its price target for Expand Energy (EXE) to $146 from $145 and kept an Overweight rating after the natural gas producer reported fourth-quarter results that beat consensus on cash flow per share, free cash flow and production. The company reported significant net-debt reduction and shareholder returns in 2025 while maintaining full-…
Scotiabank cut its 12-month price target for Palo Alto Networks to $180 from $228 while retaining a Sector Outperform rating. The bank points to muted organic momentum and increasing complexity as headwinds, even as the company reports double-digit revenue growth and pursues multiple strategic acquisitions to bolster its AI and security portfolio.
Stephens increased its price objective on Knife River Corp. (KNF) to $105 from $86 while keeping an Overweight rating following a fourth quarter that outperformed estimates across product lines. Strong volumes and firm pricing in aggregates and ready-mix concrete drove better-than-expected adjusted EBITDA margin, while contracting services and liqu…
Williams Trading lowered its rating on Crocs to Sell from Hold while lifting its price target to $84 from $75, citing deteriorating demand in the U.S. for both Crocs and HEYDUDE brands. The firm flagged retailer plans to reduce fiscal 2026 inventory and expects revenue and margin results may miss guidance despite buybacks that could support EPS per…
Wolfe Research analysts contend that Congress is unlikely to approve incremental U.S. defense funding in 2027 despite President Donald Trump’s call for a $1.5 trillion military budget. The note highlights market reactions to the proposal and argues that the sector will need to rely on existing appropriations and the fallout from international confl…
Synopsys shares rose after a regulatory filing disclosed that NVIDIA acquired roughly 4.82 million Synopsys shares, a position valued at just over $2 billion. The move places NVIDIA among the top six shareholders of the electronic design automation company. The announcement came as Synopsys shares have underperformed year-to-date amid broader press…
Canaccord Genuity trimmed its 12-month price target on AtriCure Inc. to $53 from $64 while keeping a Buy rating, citing compression in comparable company multiples. The medical device maker reported Q4 revenue of $140.5 million and positive adjusted EBITDA, and it reiterated 2026 revenue and EBITDA targets. Analyst reactions are mixed, reflecting b…
Canaccord Genuity reduced its price target for Ultragenyx Pharmaceuticals to $79 from $128 but kept a Buy rating after the company reported Q4 2025 results and announced restructuring tied to disappointing osteogenesis imperfecta news. Ultragenyx has received an information request from the FDA following a January 2026 resubmission of the UX111 bio…
Canaccord Genuity raised its price target on Holley Inc. to $8.00 from $7.00 while keeping a Buy rating, citing a return to growth and accelerating organic sales. The firm referenced dealer and reseller survey results and recent product developments as support for higher estimates. Holley is trading at $4.15 and appears below independent fair-value…
Canaccord Genuity increased its 12-month price objective on Kenvue Inc. to $18 from $17 while keeping a Hold rating. The consumer health company reported fourth-quarter and fiscal 2025 results that contained a mix of beats and misses versus different Street expectations, and management declined to host an analyst call because of the pending takeove…
Palantir’s Artificial Intelligence Platform (AIP) is producing outsized revenue and margin upside that the market sometimes mislabels as a marketing "wrapper." Fundamentals — $1.41B quarterly revenue, strong free cash flow and 2026 guidance of $7.19B — argue the product is driving substantive business growth. Valuation is rich, so this is a tactica…
UBS upgraded Rockwool International A/S to buy from neutral and lifted its 12-month price target to DKr255 from DKr240 after the company reported Q4 2025 EBIT margins above prior expectations, delivered stronger North American organic growth, and provided clearer capital expenditure guidance following two profit warnings the previous year. The bank…
L3Harris combines stable government revenue, improving profitability after strategic divestitures, and exposure to high-growth pockets like space, sensing, and secure communications. With a market cap around $64.8B, healthy free cash flow, and an improving balance sheet, we favor a measured long with clear entry, stop, and target levels over a mid-…
Needham raised its price target on Glaukos to $127 from $125 while keeping a Buy rating, citing alignment with fourth-quarter 2025 results and management's reiterated 2026 revenue guidance. The firm highlighted the ramp of iDose, the expansion pathway for Epioxa, and what it sees as ample liquidity to support commercialization. Other firms have als…
Palo Alto Networks shares dropped about 6% in pre-market trading after the company trimmed its 2026 adjusted earnings-per-share outlook, citing increased integration costs tied to recent acquisitions including CyberArk. While revenue guidance was raised, analysts note near-term margin pressure even as the company pursues a platform approach centere…
Brazil's central bank ordered the extrajudicial liquidation of Banco Pleno after determining the lender's economic and financial condition had weakened and it failed to meet regulatory requirements. The bank, controlled by Augusto Lima, was previously approved for acquisition last year and is linked to the earlier winding down of Banco Master. The …
Pinterest has revised its first-quarter guidance to account for the partial-quarter contribution from newly acquired tvScientific. The company narrowed and lowered its adjusted EBITDA range to $163 million-$183 million and raised revenue expectations to $958 million-$978 million. The acquisition closed on February 17 and is now reflected in Pintere…
Moderna shares rose following the U.S. Food and Drug Administration's decision to accept for review the company's biologics license application for its investigational seasonal influenza vaccine, mRNA-1010. The move follows a Type A meeting and a revised regulatory approach that seeks different approval pathways by age group, with a PDUFA goal date…
U.S. stock futures rose Wednesday as investors parsed a fresh wave of corporate earnings and awaited the minutes from the Federal Reserve's most recent policy meeting. Several high-profile movers stood out in pre-market trading, including gains for Nvidia, Amazon and The New York Times, and a notable drop for Palo Alto Networks after the cybersecur…
Needham has reaffirmed a Buy rating and a $45 price target on AtriCure Inc. following the company’s fourth-quarter 2025 results. While revenue matched the company preannouncement, adjusted EBITDA and earnings per share beat consensus estimates. Management reiterated 2026 revenue and adjusted EBITDA guidance and provided EPS guidance above consensus…
Upwork Inc. shares rose 6% Wednesday following the approval of a new $300 million share repurchase program. The board's action follows $136 million deployed to repurchase over 9 million shares in 2025 and brings total repurchase commitments to $600 million since November 2023. Management says the company will continue investing in SMB, AI and Enter…
Riot Platforms shares climbed 5% after Starboard Value sent a letter urging the company to accelerate deal-making for artificial intelligence and high-performance computing (AI/HPC) data centers. Starboard pointed to Riot’s 1.7 gigawatts of fully available power at Corsicana and Rockdale, praised the AMD arrangement as a positive but limited proof …
